IL-8 dictates glycosaminoglycan binding and stability of IL-18 in cystic fibrosis

Journal of Immunology

Volumn 184, Issue 3, 2010, Pages 1642-1652

  Reeves, Emer P ^a   Williamson, Michael ^a,b   Byrne, Barry ^c   Bergin, David A ^a   Smith, Stephen G J ^d   Greally, Peter ^b   O'Kennedy, Richard ^c   O'Neill, Shane J ^a   McElvaney, Noel G ^a  

^a BEAUMONT HOSPITAL   (Ireland)

^b ADELAIDE AND MEATH HOSPITAL   (Ireland)

^c DUBLIN CITY UNIVERSITY   (Ireland)

^d ST JAMES S HOSPITAL   (Ireland)

Author keywords

[No Author keywords available]

Indexed keywords

CHONDROITIN SULFATE; GLYCOSAMINOGLYCAN; HEPARAN SULFATE; HYALURONIC ACID; INTERLEUKIN 18; INTERLEUKIN 8; LEUKOCYTE ELASTASE; AUTACOID;

ARTICLE; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL ARTICLE; CONTROLLED STUDY; CYSTIC FIBROSIS; CYTOKINE PRODUCTION; ENZYME DEGRADATION; EPITHELIUM CELL; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; HUMAN TISSUE; LEUKEMIA CELL LINE; LUNG LAVAGE; MONOCYTE; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN BLOOD LEVEL; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN STABILITY; T LYMPHOCYTE; TISSUE LEVEL; ADOLESCENT; BINDING COMPETITION; BIOSYNTHESIS; CELL LINE; CHEMISTRY; CHILD; COMPARATIVE STUDY; DOWN REGULATION; IMMUNOLOGY; METABOLISM; PATHOLOGY; PHYSIOLOGY; PRESCHOOL CHILD; UPREGULATION;

ADOLESCENT; BINDING, COMPETITIVE; BRONCHOALVEOLAR LAVAGE FLUID; CELL LINE, TRANSFORMED; CHILD; CHILD, PRESCHOOL; CYSTIC FIBROSIS; DOWN-REGULATION; GLYCOSAMINOGLYCANS; HUMANS; INFLAMMATION MEDIATORS; INTERLEUKIN-18; INTERLEUKIN-8; JURKAT CELLS; PROTEIN BINDING; PROTEIN STABILITY; UP-REGULATION;

EID: 77949329602     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.0902605     Document Type: Article

References (68)

1. Stecenko, A. A., G. King, K. Torii, R. M. Breyer, R. Dworski, T. S. Blackwell, J. W. Christman, and K. L. Brigham. 2001. Dysregulated cytokine production in human cystic fibrosis bronchial epithelial cells. Inflammation 25: 145-155. (Pubitemid 32493687)
2. Hartl, D., M. Griese, M. Kappler, G. Zissel, D. Reinhardt, C. Rebhan, D. J. Schendel, and S. Krauss-Etschmann. 2006. Pulmonary T(H)2 response in Pseudomonas aeruginosa-infected patients with cystic fibrosis. J. Allergy Clin. Immunol. 117: 204-211.
3. Richman-Eisenstat, J. B., P. G. Jorens, C. A. Hébert, I. Ueki, and J. A. Nadel. 1993. Interleukin-8: an important chemoattractant in sputum of patients with chronic inflammatory airway diseases. Am. J. Physiol. 264: L413-L418.
4. Tabary, O., J. M. Zahm, J. Hinnrasky, J. P. Couetil, P. Cornillet, M. Guenounou, D. Gaillard, E. Puchelle, and J. Jacquot. 1998. Selective up-regulation of chemokine IL-8 expression in cystic fibrosis bronchial gland cells in vivo and in vitro. Am. J. Pathol. 153: 921-930.
5. Chan, E. D., H. S. Choi, C. Cool, F. J. Accurso, and G. Fantuzzi. 2002. Interleukin-18 expression in cystic fibrosis lungs. Chest 121(Suppl 3): 84S-85S.
6. Hauber, H. P., I. S. Beyer, A. Meyer, and A. Pforte. 2004. Decreased interleukin-18 expression in BAL cells and peripheral blood mononuclear cells in adult cystic fibrosis patients. J. Cyst. Fibros. 3: 129-131.
7. Muhlebach, M. S., and T. L. Noah. 2002. Endotoxin activity and inflammatory markers in the airways of young patients with cystic fibrosis. Am. J. Respir. Crit. Care Med. 165: 911-915.
8. Kettle, A. J., T. Chan, I. Osberg, R. Senthilmohan, A. L. Chapman, T. J. Mocatta, and J. S. Wagener. 2004. Myeloperoxidase and protein oxidation in the airways of young children with cystic fibrosis. Am. J. Respir. Crit. Care Med. 170: 1317-1323.
9. Kelly, E., C. M. Greene, and N. G. McElvaney. 2008. Targeting neutrophil elastase in cystic fibrosis. Expert Opin. Ther. Targets 12: 145-157.
10. Goger, B., Y. Halden, A. Rek, R. Mösl, D. Pye, J. Gallagher, and A. J. Kungl. 2002. Different affinities of glycosaminoglycan oligosaccharides for monomeric and dimeric interleukin-8: a model for chemokine regulation at inflammatory sites. Biochemistry 41: 1640-1646. (Pubitemid 34112754)
11. Marshall, L. J., L. S. Ramdin, T. Brooks, P. C. DPhil, and J. K. Shute. 2003. Plasminogen activator inhibitor-1 supports IL-8-mediated neutrophil transendothelial migration by inhibition of the constitutive shedding of endothelial IL-8/heparan sulfate/syndecan-1 complexes. J. Immunol. 171: 2057-2065.
12. Kuschert, G. S., F. Coulin, C. A. Power, A. E. Proudfoot, R. E. Hubbard, A. J. Hoogewerf, and T. N. Wells. 1999. Glycosaminoglycans interact selectively with chemokines and modulate receptor binding and cellular responses. Biochemistry 38: 12959-12968. (Pubitemid 129515595)
13. Solic, N., J. Wilson, S. J. Wilson, and J. K. Shute. 2005. Endothelial activation and increased heparan sulfate expression in cystic fibrosis. Am. J. Respir. Crit. Care Med. 172: 892-898.
14. Gracie, J. A., R. J. Forsey, W. L. Chan, A. Gilmour, B. P. Leung, M. R. Greer, K. Kennedy, R. Carter, X. Q. Wei, D. Xu, et al. 1999. A proinflammatory role for IL-18 in rheumatoid arthritis. J. Clin. Invest. 104: 1393-1401.
15. Greene, C. M., G. Meachery, C. C. Taggart, C. P. Rooney, R. Coakley, S. J. O'Neill, and N. G. McElvaney. 2000. Role of IL-18 in CD4+ T lymphocyte activation in sarcoidosis. J. Immunol. 165: 4718-4724.
16. Imaoka, H., T. Hoshino, S. Takei, T. Kinoshita, M. Okamoto, T. Kawayama, S. Kato, H. Iwasaki, K. Watanabe, and H. Aizawa. 2008. Interleukin-18 production and pulmonary function in COPD. Eur. Respir. J. 31: 287-297.
17. Takeda, K., H. Tsutsui, T. Yoshimoto, O. Adachi, N. Yoshida, T. Kishimoto, H. Okamura, K. Nakanishi, and S. Akira. 1998. Defective NK cell activity and Th1 response in IL-18-deficient mice. Immunity 8: 383-390. (Pubitemid 28188898)
18. Kim, S. H., M. Eisenstein, L. Reznikov, G. Fantuzzi, D. Novick, M. Rubinstein, and C. A. Dinarello. 2000. Structural requirements of six naturally occurring isoforms of the IL-18 binding protein to inhibit IL-18. Proc. Natl. Acad. Sci. USA97: 1190-1195.
19. Robertson, S. E., J. D. Young, S. Kitson, A. Pitt, J. Evans, J. Roes, D. Karaoglu, L. Santora, T. Ghayur, F. Y. Liew, et al. 2006. Expression and alternative processing of IL-18 in human neutrophils. Eur. J. Immunol. 36: 722-731.
20. Wieland, C. W., B. Siegmund, G. Senaldi, M. L. Vasil, C. A. Dinarello, and G. Fantuzzi. 2002. Pulmonary inflammation induced by Pseudomonas aeruginosa lipopolysaccharide, phospholipase C, and exotoxin A: role of interferon regulatory factor 1. Infect. Immun. 70: 1352-1358.
21. Bergsson, G., E. P. Reeves, P. McNally, S. H. Chotirmall, C. M. Greene, P. Greally, P. Murphy, S. J. O'Neill, and N. G. McElvaney. 2009. LL-37 complexation with glycosaminoglycans in cystic fibrosis lungs inhibits antimicrobial activity, which can be restored by hypertonic saline. J. Immunol. 183: 543-551.
22. Kelly, D. M., C. M. Greene, G. Meachery, M. O'Mahony, P. M. Gallagher, C. C. Taggart, S. J. O'Neill, and N. G. McElvaney. 2005. Endotoxin up-regulates interleukin-18: potential role for gram-negative colonization in sarcoidosis. Am. J. Respir. Crit. Care Med. 172: 1299-1307.
23. Cozens, A. L., M. J. Yezzi, L. Chin, E. M. Simon, W. E. Finkbeiner, J. A. Wagner, and D. C. Gruenert. 1992. Characterization of immortal cystic fibrosis tracheobronchial gland epithelial cells. Proc. Natl. Acad. Sci. USA 89: 5171-5175.
24. Bergin, D. A., C. M. Greene, E. E. Sterchi, C. Kenna, P. Geraghty, A. Belaaouaj, A. Belaaouaj, C. C. Taggart, S. J. O'Neill, and N. G. McElvaney. 2008. Activation of the epidermal growth factor receptor (EGFR) by a novel metalloprotease pathway. [Published erratum appears in 2009 J. Biol. Chem. 284: 9624.] J. Biol. Chem. 283: 31736-31744.
25. Zeitlin, P. L., L. Lu, J. Rhim, G. Cutting, G. Stetten, K. A. Kieffer, R. Craig, and W. B. Guggino. 1991. A cystic fibrosis bronchial epithelial cell line: immortalization by adeno-12-SV40 infection. Am. J. Respir. Cell Mol. Biol. 4: 313-319.
26. Rahmoune, H., G. Lamblin, J. J. Lafitte, C. Galabert, M. Filliat, and P. Roussel. 1991. Chondroitin sulfate in sputum from patients with cystic fibrosis and chronic bronchitis. Am. J. Respir. Cell Mol. Biol. 5: 315-320.
27. Wyatt, H. A., A. Dhawan, P. Cheeseman, G. Mieli-Vergani, and J. F. Price. 2002. Serum hyaluronic acid concentrations are increased in cystic fibrosis patients with liver disease. Arch. Dis. Child. 86: 190-193.
28. Reeves, E. P., T. Ali, P. Leonard, S. Hearty, R. O'Kennedy, F. E. May, B. R. Westley, C. Josenhans, M. Rust, S. Suerbaum, A. Smith, B. Drumm, and M. Clyne. 2008. Helicobacter pylori lipopolysaccharide interacts with TFF1 in a pH-dependent manner. Gastroenterology 135: 2043-2054, 2054.e1-2.
29. Chen, S. S., and P. C. Engel. 1975. Dogfish M4 lactate dehydrogenase: reversible inactivation by pyridoxal 5′-phosphate and complete protection in complexes that mimic the active ternary complex. Biochem. J. 151: 447-449.
30. Swanborg, R. H. 1970. The effect of selective modification of tryptophan, lysine and arginine residues of basic brain protein on encephalitogenic activity. J. Immunol. 105: 865-871.
31. Frevert, C. W., M. G. Kinsella, C. Vathanaprida, R. B. Goodman, D. G. Baskin, A. Proudfoot, T. N. Wells, T. N. Wight, and T. R. Martin. 2003. Binding of interleukin-8 to heparan sulfate and chondroitin sulfate in lung tissue. Am. J. Respir. Cell Mol. Biol. 28: 464-472.
32. Tate, S., G. MacGregor, M. Davis, J. A. Innes, and A. P. Greening. 2002. Airways in cystic fibrosis are acidified: detection by exhaled breath condensate. Thorax 57: 926-929. (Pubitemid 35316268)
33. Newport, S., N. Amin, and A. J. Dozor. 2009. Exhaled breath condensate pH and ammonia in cystic fibrosis and response to treatment of acute pulmonary exacerbations. Pediatr. Pulmonol. 44: 866-872.
34. Kato, Z., J. Jee, H. Shikano, M. Mishima, I. Ohki, H. Ohnishi, A. Li, K. Hashimoto, E. Matsukuma, K. Omoya, et al. 2003. The structure and binding mode of interleukin-18. Nat. Struct. Biol. 10: 966-971.
35. Webb, L. M., M. U. Ehrengruber, I. Clark-Lewis, M. Baggiolini, and A. Rot. 1993. Binding to heparan sulfate or heparin enhances neutrophil responses to interleukin 8. Proc. Natl. Acad. Sci. USA 90: 7158-7162.
36. Kawakami, K., Y. Koguchi, M. H. Qureshi, Y. Kinjo, S. Yara, A. Miyazato, M. Kurimoto, K. Takeda, S. Akira, and A. Saito. 2000. Reduced host resistance and Th1 response to Cryptococcus neoformans in interleukin-18 deficient mice. FEMS Microbiol. Lett. 186: 121-126.
37. Khan, T. Z., J. S. Wagener, T. Bost, J. Martinez, F. J. Accurso, and D. W. Riches. 1995. Early pulmonary inflammation in infants with cystic fibrosis. Am. J. Respir. Crit. Care Med. 151: 1075-1082.
38. Tirouvanziam, R., Y. Gernez, C. K. Conrad, R. B. Moss, I. Schrijver, C. E. Dunn, Z. A. Davies, L. A. Herzenberg, and L. A. Herzenberg. 2008. Profound functional and signaling changes in viable inflammatory neutrophils homing to cystic fibrosis airways. Proc. Natl. Acad. Sci. USA 105: 4335-4339.
39. Moss, R. B., Y. P. Hsu, and L. Olds. 2000. Cytokine dysregulation in activated cystic fibrosis (CF) peripheral lymphocytes. Clin. Exp. Immunol. 120: 518-525.
40. Joseph, T., D. Look, and T. Ferkol. 2005. NF-kappaB activation and sustained IL-8 gene expression in primary cultures of cystic fibrosis airway epithelial cells stimulated with Pseudomonas aeruginosa. Am. J. Physiol. Lung Cell. Mol. Physiol. 288: L471-L479.
41. Smith, S. F., A. Guz, G. H. Burton, R. Heaton, N. T. Cooke, and T. D. Tetley. 1988. The elastase: anti-elastase profile in lung lavage from sarcoidosis patients. Sarcoidosis 5: 31-37.
42. Okamura, H., H. Tsutsui, S. Kashiwamura, T. Yoshimoto, and K. Nakanishi. 1998. Interleukin-18: a novel cytokine that augments both innate and acquired immunity. Adv. Immunol. 70: 281-312.
43. Jaffar-Bandjee, M. C., A. Lazdunski, M. Bally, J. Carrère, J. P. Chazalette, and C. Galabert. 1995. Production of elastase, exotoxin A, and alkaline protease in sputa during pulmonary exacerbation of cystic fibrosis in patients chronically infected by Pseudomonas aeruginosa. J. Clin. Microbiol. 33: 924-929.
44. Meyer, K. C., and A. Sharma. 1997. Regional variability of lung inflammation in cystic fibrosis. Am. J. Respir. Crit. Care Med. 156: 1536-1540.
45. Bhattacharyya, S., K. Solakyildirim, Z. Zhang, M. L. Chen, R. J. Linhardt, and J. K. Tobacman. 2009. Cell-bound IL-8 Increases in bronchial epithelial cells following arylsulfatase B silencing. Am. J. Respir. Cell Mol. Biol. doi:10.1165/rcmb.2008-0482OC
46. Arteel, G. E., S. Franken, J. Kappler, and H. Sies. 2000. Binding of selenoprotein P to heparin: characterization with surface plasmon resonance. Biol. Chem. 381: 265-268.
47. Gandhi, N. S., D. R. Coombe, and R. L. Mancera. 2008. Platelet endothelial cell adhesion molecule 1 (PECAM-1) and its interactions with glycosaminoglycans: 1. Molecular modeling studies. Biochemistry 47: 4851-4862.
48. Krieger, E., E. Geretti, B. Brandner, B. Goger, T. N. Wells, and A. J. Kungl. 2004. A structural and dynamic model for the interaction of interleukin-8 and glycosaminoglycans: support from isothermal fluorescence titrations. Proteins 54: 768-775.
49. Sebollela, A., T. C. Cagliari, G. S. Limaverde, A. Chapeaurouge, M. H. Sorgine, T. Coelho-Sampaio, C. H. Ramos, and S. T. Ferreira. 2005. Heparin-binding sites in granulocyte-macrophage colony-stimulating factor. Localization and regulation by histidine ionization. J. Biol. Chem. 280: 31949-31956.
50. Alexis, N. E., M. S. Muhlebach, D. B. Peden, and T. L. Noah. 2006. Attenuation of host defense function of lung phagocytes in young cystic fibrosis patients. J. Cyst. Fibros. 5: 17-25.
51. Marquezini, M. V., C. M. Strunz, L. A. Dallan, and O. M. Toledo. 1995. Glycosaminoglycan distribution in atherosclerotic saphenous vein grafts. Cardiology 86: 143-146.
52. Bhaskar, K. R., B. S. Turner, S. A. Grubman, D. M. Jefferson, and J. T. LaMont. 1998. Dysregulation of proteoglycan production by intrahepatic biliary epithelial cells bearing defective (δ-f508) cystic fibrosis transmembrane conductance regulator. Hepatology 27: 7-14.
53. Hilliard, T. N., N. Regamey, J. K. Shute, A. G. Nicholson, E. W. Alton, A. Bush, and J. C. Davies. 2007. Airway remodelling in children with cystic fibrosis. Thorax 62: 1074-1080.
54. Khatri, I. A., K. R. Bhaskar, J. T. Lamont, S. U. Sajjan, C. K. Ho, and J. Forstner. 2003. Effect of chondroitinase ABC on purulent sputum from cystic fibrosis and other patients. Pediatr. Res. 53: 619-627.
55. Sahu, S. C. 1980. Hyaluronic acid. An indicator of pathological conditions of human lungs? Inflammation 4: 107-112.
56. Dreisbach, A. W., and V. Batuman. 1994. Low-molecular-weight protein competition for binding sites on renal brush border membranes. Ren. Physiol. Biochem. 17: 287-293.
57. Elass, E., M. Masson, J. Mazurier, and D. Legrand. 2002. Lactoferrin inhibits the lipopolysaccharide-induced expression and proteoglycan-binding ability of interleukin-8 in human endothelial cells. Infect. Immun. 70: 1860-1866.
58. Rogan, M. P., C. C. Taggart, C. M. Greene, P. G. Murphy, S. J. O'Neill, and N. G. McElvaney. 2004. Loss of microbicidal activity and increased formation of biofilm due to decreased lactoferrin activity in patients with cystic fibrosis. J. Infect. Dis. 190: 1245-1253.
59. Proudfoot, A. E., T. M. Handel, Z. Johnson, E. K. Lau, P. LiWang, I. Clark-Lewis, F. Borlat, T. N. Wells, and M. H. Kosco-Vilbois. 2003. Glycosaminoglycan binding and oligomerization are essential for the in vivo activity of certain chemokines. Proc. Natl. Acad. Sci. USA 100: 1885-1890.
60. Sadir, R., E. Forest, and H. Lortat-Jacob. 1998. The heparan sulfate binding sequence of interferon-g increased the on rate of the interferon-γ-interferon-γ receptor complex formation. J. Biol. Chem. 273: 10919-10925.
61. Lortat-Jacob, H., and J. A. Grimaud. 1991. Interferon-γ binds to heparan sulfate by a cluster of amino acids located in the C-terminal part of the molecule. FEBS Lett. 280: 152-154.
62. Lortat-Jacob, H., F. Baltzer, and J. A. Grimaud. 1996. Heparin decreases the blood clearance of interferon-γ and increases its activity by limiting the processing of its carboxyl-terminal sequence. J. Biol. Chem. 271: 16139-16143.
63. Ito, Y., A. Saeki, K. Shiroyama, N. Sugioka, and K. Takada. 2008. Percutaneous absorptionof interferon-α byself-dissolvingmicropiles. J. Drug Target. 16: 243-249.
64. Leavell, K. J., M. W. Peterson, and T. J. Gross. 1997. Human neutrophil elastase abolishes interleukin-8 chemotactic activity. J. Leukoc. Biol. 61: 361-366.
65. Cantor, J. O., J. M. Cerreta, G. Armand, and G. M. Turino. 1998. Aerosolized hyaluronic acid decreases alveolar injury induced by human neutrophil elastase. Proc. Soc. Exp. Biol. Med. 217: 471-475.
66. Douglas, M. S., D. A. Rix, J. H. Dark, D. Talbot, and J. A. Kirby. 1997. Examination of the mechanism by which heparin antagonizes activation of a model endothelium by interferon-γ (IFN-γ). Clin. Exp. Immunol. 107: 578-584.
67. Baltus, T., K. S. Weber, Z. Johnson, A. E. Proudfoot, and C. Weber. 2003. Oligomerization of RANTES is required for CCR1-mediated arrest but not CCR5-mediated transmigration of leukocytes on inflamed endothelium. Blood 102: 1985-1988.
68. Cripps, J. G., F. A. Crespo, P. Romanovskis, A. F. Spatola, and R. Fernández-Botrán. 2005. Modulation of acute inflammation by targeting glycosaminoglycan-cytokine interactions. Int. Immunopharmacol. 5: 1622-1632.